AVROBIO, Inc.

https://www.avrobio.com/
Tags:BiopharmaBioTechBodyLearnPlatformStorageTechnology
Biotechnology company developing lentiviral-based gene therapies to treat lysosomal storage disorders (LSDs)
Location: United States, Cambridge
Total raised: $85M

Investors 3

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
01.02.2018Series B$60M--
02.08.2016Series A$25M--

Mentions in press and media 10

DateTitleDescriptionCategoryAuthorSource
05.02.2018Capitalizi...Announced Thursday, the raise ...--medcitynew...
02.02.2018Term Sheet...IPO DELAYS Good morning, Term...--fortune.co...
01.02.2018Avrobio Ra...Avrobio, a Cambridge, Mass.-ba...USA-finsmes.co...
01.02.2018AVROBIO, I...CAMBRIDGE, Mass.–(BUSINESS WIR...--aislingcap...
01.02.2018AVROBIO, I...Company to initiate Phase 2 tr...--svhealthin...
01.02.2018AVROBIO Ra...AVROBIO, Inc., a clinical-stag...--citybizlis...
02.08.2016Avrobio Ra...Avrobio, Inc., a Cambridge, MA...USA-finsmes.co...
02.08.2016AVROBIO Ra...CAMBRIDGE, Mass.--(BUSINESS WI...--citybizlis...
18.02.2016Avrobio Ra...Avrobio, a Cambridge, MA and T...Canada US...-finsmes.co...
18.02.2016Atlas Vent...AvroBio’s second program, AVR-...--medcitynew...